News

The BROADEN (BROdmann Area 25 DEep brain Neuromodulation) study will evaluate the safety and effectiveness of deep brain stimulation in patients with depression for whom currently-available treatments are

Calibrant will identify proteins and protein networks involved in ovarian and breast cancer, as well as select novel therapeutic targets found to be central to disease progression. Fattaneh

The funding is part of the Maryland Technology Development’s Maryland Technology Transfer Fund (TEDCO MTTF) and the Maryland Venture Fund’s Challenge Investment Program. Using proprietary tissue processing technologies,

The application is based upon clinical data which include the results from the company’s Phase III multi-center, international, randomized study of Vidaza (azacitidine for injection) in the treatment

Under the research collaboration agreement, London Genetics’s partner, University College London (UCL), will replicate Genizon’s findings from the genome-wide association study that identified multiple genes associated with schizophrenia

New FDA-cleared indications for the Waterlase MD Derm device include incision, excision, ablation, vaporization and coagulation of dermatologic tissues including epidermal nevi, cheilitis, keloids, verrucae, skin tags, keratosis,

Under the terms of the agreement, Medicago will grant the partner two million common share purchase warrants. Each warrant entitles the partner the right to acquire one common

Additionally the company has reported that it has changed its name from Axela Biosensors to Axela, to reflect the broad range of applications and markets served by its

The committee reviewed data from a comprehensive clinical program comprising eight studies. Results from the clinical trials showed greater symptom improvement in Zyprexa long-acting injection (LAI) treated patients,